日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Consequences of the Updated Hemodynamic Criteria for the Classification of Chronic Thromboembolic Pulmonary Disease

更新后的血流动力学标准对慢性血栓栓塞性肺疾病分类的影响

van Kan, Coen; Hardy, Laura; Stok, Niki; Kianzad, Azar; Nossent, Esther; Aman, Jurjan; Meijboom, Lilian; Quarck, Rozenn; Delcroix, Marion; Bogaard, Harm Jan; Vonk Noordegraaf, Anton; van Es, Josien

Disease-Drug-Drug Interaction of Imatinib in COVID-19 ARDS: A Pooled Population Pharmacokinetic Analysis

伊马替尼在 COVID-19 ARDS 中的疾病-药物-药物相互作用:一项汇总人群药代动力学分析

Said, Medhat M; Schippers, Job R; Atmowihardjo, Leila; Li, Yingxue; van der Plas, Mick S; Bogaard, Harm J; Bos, Lieuwe D J; Mathôt, Ron A A; Aman, Jurjan; Swart, Eleonora L; Bartelink, Imke H

Similar quality of life after balloon pulmonary angioplasty or pulmonary endarterectomy for CTEPH

慢性血栓栓塞性肺动脉高压患者行球囊肺动脉成形术或肺动脉内膜剥脱术后,生活质量相似。

Smeele, P; Braams, N J; Vermunt, L; Kianzad, A; Rodenburg, T C; Stilling, E; Andersen, S; Andersen, M J; Mellemkjær, S; Nossent, E J; Aman, Jurjan; Beijk, M A M; Lely, R J; Winkelman, J A; Oosterveer, F; Marcus, T; Vonk Noordegraaf, A; Meijboom, L J; Teunissen, C E; Andersen, A; Bogaard, H J

Deep phenotyping of unaffected carriers of pathogenic BMPR2 variants screened for pulmonary arterial hypertension

对携带致病性BMPR2变异但未患病的个体进行肺动脉高压筛查,并进行深度表型分析。

Tóth, Eszter N; Celant, Lucas R; Niglas, Marili; Jansen, Samara; Tramper, Jelco; Baxan, Nicoleta; Ashek, Ali; Wessels, Jeroen N; Marcus, J Tim; Meijboom, Lilian J; Houweling, Arjan C; Nossent, Esther J; Aman, Jurjan; Grynblat, Julien; Perros, Frédéric; Montani, David; Vonk Noordegraaf, Anton; Zhao, Lan; de Man, Frances S; Bogaard, Harm Jan

Pathology and pathobiology of pulmonary hypertension: current insights and future directions

肺动脉高压的病理学和病理生物学:当前认识和未来方向

Guignabert, Christophe; Aman, Jurjan; Bonnet, Sébastien; Dorfmüller, Peter; Olschewski, Andrea J; Pullamsetti, Soni; Rabinovitch, Marlene; Schermuly, Ralph T; Humbert, Marc; Stenmark, Kurt R

Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients.

纵向血浆蛋白质组学揭示了 COVID-19 重症患者肺泡毛细血管屏障破坏的生物标志物

Duijvelaar Erik, Gisby Jack, Peters James E, Bogaard Harm Jan, Aman Jurjan

Imatinib treatment improves hyperglycaemic dysregulation in severe COVID-19: a secondary analysis of blood biomarkers in a randomised controlled trial

伊马替尼治疗可改善重症 COVID-19 患者的高血糖症:一项随机对照试验中血液生物标志物的二次分析

Duijvelaar, Erik; Pan, Xiaoke; Bogaard, Harm Jan; Eringa, Etto C; Aman, Jurjan

Author Correction: Mechanical stimulation of induced pluripotent stem cell derived cardiac fibroblasts

作者更正:诱导多能干细胞衍生的心脏成纤维细胞的机械刺激

Bekedam, Fjodor T; Smal, Rowan; Smit, Marisa C; Aman, Jurjan; Vonk-Noordegraaf, Anton; Bogaard, Harm Jan; Goumans, Marie José; De Man, Frances S; Llucià-Valldeperas, Aida

Pneumonectomy combined with SU5416 or monocrotaline pyrrole does not cause severe pulmonary hypertension in mice

肺切除术联合使用SU5416或单克罗他林吡咯不会引起小鼠严重肺动脉高压。

Sun, Xiao-Qing; Klouda, Timothy; Barnasconi, Suzanne; Schalij, Ingrid; Schwab, Janne; Nielsen-Kudsk, Anders Hammer; Axelsen, Julie Sørensen; Andersen, Asger; Aman, Jurjan; de Man, Frances S; Bogaard, Harm Jan; Yuan, Ke; Yoshida, Keimei

Correlation between Serum Biomarkers and Lung Ultrasound in COVID-19: An Observational Study.

COVID-19 患者血清生物标志物与肺部超声的相关性:一项观察性研究

Mousa Amne, Blok Siebe G, Karssen Dian, Aman Jurjan, Annema Jouke T, Bogaard Harm Jan, Bonta Peter I, Haaksma Mark E, Heldeweg Micah L A, Lieveld Arthur W E, Nanayakkara Prabath, Nossent Esther J, Smit Jasper M, Smit Marry R, Vlaar Alexander P J, Schultz Marcus J, Bos Lieuwe D J, Paulus Frederique, Tuinman Pieter R, Amsterdam Umc Covid-Biobank Investigators